Effect of RUNX3 on the Expression of Smad4 in T24 Bladder Cancer Cell Line

LIU Jing, LI Li-jun, QIU Ming-xing

Abstract

To examine the effects of RUNX3 on cell proliferation and apoptosis and the expression level of Smad4 mRNA in the bladder cancer cell line of T24 by transfection with recombinant plasmid of pIRES-EGFP-RUNX3. Methods The recombinant plasmid of pIRES-EGFP-RUNX3 was constructed successfully. Cultured T24 cells were divided into three groups, including control group, empty vector group,and recombinant plasmid group. The cells in empty vector group and recombinant plasmid group were respectively transfected by pIRES-EGFP and pIRES-EGFP-RUNX3./i> The cells were harvested at 24 h after the transfection, the variation of cell morphology was examined by fluorescence microscopy. The cell apoptosis was detected by flow cytometry. The expression level of RUNX3 and Smad4 mRNA was measured by RT-PCR. Results Cell death was observed in two transfection groups. At 24 h after transfection,the apoptosis rate was (3.23±0.45)% in control group, (8.98±1.62)% in empty vector group and (43.61±2.69)% in recombinant plasmid group. The expression level of RUNX3 mRNA was 2.79±0.36,detected only in recombinant plasmid group, which was significantly up-regulated compared with the other two groups (P <0.05).Conclusion The expression level of Smad4 mRNA was up-regulated by transfection with pIRES-EGFP-RUNX3,which also inhibited cell proliferation and promoted cell apoptosis.The tumor suppressor gene of RUNX3 could regulate the bladder cancer cell proliferation and apoptosis by TGF-β/Smad signaling pathway.

 

Keywords: RUNX3, Transforming growth factor-β, Smad4, Bladder cancer 

 

Full Text:

PDF


References


ITO Y.MIYAZONO K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev,2003,13(1):43-47.

BAP" SC,CHOI JK. Tumor suppressor activity of RUNX3. Oncogene,2004,23(24):4336-4340.

WATANABE K,SUGAI M.NAMBU Y,et al. Requirement for Runx proteins in IgA class switching acting downstream of TGF-beta 1 and retinoic acid signaling. J Immunol, 2010. 184(6);2785-2792.

FAINARU (). WOOLF E, LOTEM J, et at. RUNX3 regulates mouse TGF-p-mediated dendritic cell function and its absence results in airway inflammation. EMBC) J.2004.23 (4):969-979.

ZHU B. KYPRIANOU N. Transforming growth factor beta and prostate cancer. Cancer Treat Res,2005( 126); 157-173. ATTISANO L, LEE-HOEFLICH ST. The Smads. Genome Biol,2001,2(8);REVIEWS3010[2015-11-12]. http://www. ncbi. nlm. nih. gov /рте/articles /РМС138956/.

NICOLAS FJ, HILL CS. Attenuation of the TGF-p-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-(3-induced growth arrest. Oncogene, 2003 , 22 ( 24 ): 3698-3711.

LiNX, LIANG M. LIANG YY, et al. Activation of transforming growth factor-beta signaling by SUMO-l modification of tumor suppressor Smad4/DPC4. J Biol Chem, 2003,278(21):18714-18719.

TAKAKU K, OSHIMA M, MIYOSHI H, et al. Intestinal tumorigenesis in compound mutant mice of both I)pc4 (Smad4) and Ape genes. Cell, 1998,92(5) ;645-656.

ZAIDISK. SULLIVAN AJ, VAN WIJNEN AJ, et al. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci U S A*2002.99(12):8048-8053.


Refbacks

  • There are currently no refbacks.